8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This was a single center, retrospective cross-sectional study looking into the incidence and types of drug-related problems (DRPs) detected among elderly cancer patients receiving at least three long-term medications concurrent with IV chemotherapy, and the types of intervention taken to address these DRPs. This paper serves to elucidate the prevalence and risk of polypharmacy in our geriatric oncology population in an ambulatory care setting, to raise awareness on this growing issue and to encourage more resource allocation to address this healthcare phenomenon.

          Related collections

          Author and article information

          Journal
          Curr Oncol Rep
          Current oncology reports
          Springer Nature
          1534-6269
          1523-3790
          Mar 26 2018
          : 20
          : 5
          Affiliations
          [1 ] Department of Pharmacy, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
          [2 ] Department of Pharmacy, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore. lita.chew@nccs.com.sg.
          [3 ] Department of Pharmacy, National University of Singapore, Singapore, Singapore. lita.chew@nccs.com.sg.
          Article
          10.1007/s11912-018-0686-x
          10.1007/s11912-018-0686-x
          29582192
          65ca84ad-09c4-4f74-aeee-667fc2759f4a
          History

          Ambulatory care,Drug-related problems,Elderly cancer patients,Geriatric oncology,Long-term medications,Medication therapy management,Outpatient chemotherapy,Polypharmacy

          Comments

          Comment on this article

          Related Documents Log